Trumbull, Connecticut – January 17, 2018 – Recognizing the need for a simple yet comprehensive guide outlining key pharmaceutical benefit industry terms, Access Market Intelligence (AMI) has introduced an e-book, Common Drug Related Terms and Acronyms. The book is available online at Amazon Books or at the AMI website for $20.00.
Covering the most commonly used terms in today’s evolving benefits industry, the book contains concise easy-to-understand definitions as well as a list of acronyms frequently heard in the pharmaceutical benefits arena. It was developed for use by clinicians and non-clinicians involved in the daily design of pharmacy benefit programs.
Terms like most-favored-nation and acronyms like PUPM and AWP must be fully understood to participate successfully in the pharmaceutical benefits marketplace. The 2018 edition of Glossary of Common Drug Related Terms and Acronyms gives readers the information needed to communicate effectively and to understand the inner workings of this dynamic industry.
Developed with benefit and pharmacist thought leaders at Access Market Intelligence (AMI), a Founder of the National Institute for Collaborative Health (NICH), and in conjunction with the Institute for Integrated Healthcare (IIH) this is a must-have book for anyone involved in, or interested in, the medical, pharmaceutical or health benefits marketplace.
“With worldwide pharmaceutical sales expected to top more than $1 trillion over the next few years, the number of physicians, care providers or payers, benefits administrators and healthcare leaders involved in the industry continues to skyrocket,” said Randy Vogenberg, Ph.D., R.Ph., Principal with IIH, and a national expert on managed care, commercial health benefits and plan design, health-system delivery & economics, and health innovation research. “But the healthcare benefits marketplace has a language all its own; and to participate and excel, you need to communicate with the language and terms used by industry leaders.”
The 2018 edition of Glossary of Common Drug Related Terms and Acronyms provides the information needed to communicate effectively and understand the inner workings of this dynamic industry. The glossary of terms is the first book among other contemporary titles that are in development by AMI. AMI also has additional reports and insight papers available online. The glossary represents AMI’s inaugural book entry.
Access Market Intelligence provides fresh market insights and strategy consulting to benefit advisors, health systems, employers, health plans/PBMs and biologics and specialty pharmacy issues. With expert insights into market trends, AMI enables better adaptation to market changes and effective leveraging of marketing budgets that have proved dramatically beneficial for healthcare businesses across the industry. AMI’s team is on the front lines advancing concepts on healthcare reform, healthcare policy, disseminating education through publications, participating on academic advisory boards to advance clinical and economic outcomes for healthcare. For more information visit www.accessmarketintell.com.